Sort
59,101 grants matching “hypertension”
Ectopic Fat, Adipocytokines, and Atherosclerosis in Postmenopausal Women
$809,581Rachel P Wildman · Albert Einstein College Of Medicine · R01 · FY2010 · HL
Chronic Kidney Disease in Children Study (C-Kid)
$809,580Susan L Furth · Johns Hopkins University · U01 · FY2007 · DK
Cutaneous uric acid and metabolite monitoring to improve individual response to pharmaceutical and dietary treatment in patients with gout
$809,473Wei Gao · California Institute Of Technology · R33 · FY2025 · DK
Mitochondrial DNA Copy Number and Genetic Variation in Coronary Heart Disease
$809,364Dan E Arking · Johns Hopkins University · R01 · FY2016 · HL
Peer Empowerment Program for Physical Activity in Low Income & Minority Seniors
$809,140Jacqueline Kerr · University Of California, San Diego · R01 · FY2017 · HL
Comparative Genomics of Non-Coding Regions to Facilitate Translational Research
$809,044Inna Dubchak · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2011 · HL
Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension
$809,000Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2023 · HL
Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension
$808,999Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2024 · HL
Self-management behaviors among COPD patients with multi-morbidity
$808,961Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · HL
Leveraging a Natural Experiment to Estimate the Effects of School Racial Segregation on Cardiovascular Risk Factors among Youth and Young Adults
$808,862Rita Hamad · University Of California, San Francisco · R01 · FY2020 · HL
Understanding and Improving Adherence in HIV Disease
$808,862Tufts Medical Center · R01 · FY2004 · DA
PREMIER--LIFESTYLE INTERVEN FOR BLOOD PRESSURE CONTROL
$808,758Kaiser Foundation Research Institute · U01 · FY2000 · HL
Mediators of Systemic Inflammation and Heart Failure Risk in the Community
$808,739Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2022 · HL
Informing optimal first-line antihypertensive therapy: A rigorous comparative effectiveness analysis of ARBs vs. ACEIs on long-term risk of dementia, cancer, heart disease, and quality of life
$808,711Jordana B. Cohen · University Of Pennsylvania · R01 · FY2022 · AG
Placenta-derived extracellular circulating RNA as a tool for monitoring placental function
$808,512Zev Williams · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · HD
CORAL: Data Coordinating Center
$808,482Donald Cutlip · Beth Israel Deaconess Medical Center · U01 · FY2007 · HL
Mechanisms of hypertension in women with polycystic ovary syndrome
$808,427Nina Stachenfeld · John B. Pierce Laboratory, Inc. · R01 · FY2019 · HL
TASK AREA A - MESA CORE OPERATIONS, FIELD CENTER.
$808,268Karol Watson · University Of California Los Angeles · N01 · FY2024 · HL
Mechanisms of hypertension in women with polycystic ovary syndrome
$808,175Nina Stachenfeld · John B. Pierce Laboratory, Inc. · R01 · FY2021 · HL
Drugs On Learned & Spontaneous Behavior Of Experimental Animals
$808,120Steven Goldberg · National Institute On Drug Abuse · ZIA · FY2013 · DA
Development of a pedigreed baboon genome resource for biomedical research
$808,087Jeffrey D Wall · University Of California, San Francisco · R24 · FY2015 · OD
Structure and function of voltage-gated calcium channels
$808,022Daniel L Minor · University Of California, San Francisco · R01 · FY2022 · HL
Structure and function of voltage-gated calcium channels
$808,022Daniel L Minor · University Of California, San Francisco · R01 · FY2021 · HL
Structure and function of voltage-gated calcium channels
$808,022Daniel L Minor · University Of California, San Francisco · R01 · FY2023 · HL
TOPMed WGS and Molecular Epidemiology Analyses for Cardiac Hypertrophy Phenotypes
$807,948Ulrich Broeckel · Medical College Of Wisconsin · R56 · FY2023 · HL